Anthony Carestia

Title: Anthony Carestia: Innovator in Therapeutic Compounds

Introduction

Anthony Carestia is a notable inventor based in Greensboro, NC (US). He has made significant contributions to the field of therapeutic compounds, particularly in the development of salts and esters of APX3330. His work focuses on innovative solutions for treating various diseases.

Latest Patents

Anthony Carestia holds a patent for "Salts and esters of APX3330 and therapeutic uses thereof." This invention relates to Compound 1 (APX3330) salts and esters. The patent also provides compositions comprising a Compound 1 salt or ester. Furthermore, it includes compounds of formula (I) and formula (II) and pharmaceutically acceptable salts thereof. The invention outlines methods for treating or preventing diseases such as cancer, liver disorders, ocular disorders, cardiovascular disorders, fibrosis, or inflammatory disorders. This is achieved by administering an effective amount of a Compound 1 salt or ester, or a compound of formula (I) or formula (II), or pharmaceutically acceptable salt thereof.

Career Highlights

Anthony Carestia is currently associated with Opus Genetics, Inc., where he continues to advance his research and development efforts. His innovative approach has led to the creation of valuable therapeutic compounds that have the potential to improve patient outcomes.

Collaborations

Anthony has collaborated with talented individuals such as Daniela Carmen Oniciu and Corina-Mihaela Manta. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking therapeutic solutions.

Conclusion

Anthony Carestia's contributions to the field of therapeutic compounds exemplify the impact of innovation in medicine. His work on APX3330 and its derivatives showcases the potential for new treatments that can address significant health challenges.